T Cell Assays and MIATA: The Essential Minimum for Maximum Impact
Open Access
- 27 July 2012
- journal article
- other
- Published by Elsevier BV in Immunity
- Vol. 37 (1), 1-2
- https://doi.org/10.1016/j.immuni.2012.07.010
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Toward interoperable bioscience dataNature Genetics, 2012
- The problems and promises of research into human immunology and autoimmune diseaseNature Medicine, 2012
- Harmonization of Immune Biomarker Assays for Clinical StudiesScience Translational Medicine, 2011
- Novel cancer immunotherapy agents with survival benefit: recent successes and next stepsNature Reviews Cancer, 2011
- A methodological framework to enhance the clinical success of cancer immunotherapyNature Biotechnology, 2011
- Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyondCancer Immunology, Immunotherapy, 2010
- A model for harmonizing flow cytometry in clinical trialsNature Immunology, 2010
- “MIATA”—Minimal Information about T Cell AssaysImmunity, 2009
- A Prescription for Human ImmunologyImmunity, 2008